Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:AZTD NYSEARCA:LST NASDAQ:NITE NYSEARCA:WMW On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAZTDAztlan Global Stock Selection DM SMID ETF$27.21-0.6%$26.74$20.12▼$28.17$30.61M1.031,876 shs1,967 shsLSTLeuthold Select Industries ETF$36.12-1.3%$36.06$29.04▼$37.14$27.34MN/A4,877 shs6,890 shsNITENightstar Therapeutics$31.22-2.6%$25.41$9.59▼$29.55$1.05B2.84185,808 shs868 shsWMWELEMENTS Linked to the Morningstar Wide Moat Focus Total Return Index$0.00$28.08▼$39.22$18.99MN/A3,163 shs20,900 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAZTDAztlan Global Stock Selection DM SMID ETF-0.62%-3.34%+0.67%+10.93%+22.90%LSTLeuthold Select Industries ETF-1.34%-2.25%-1.63%+7.79%+3,611,999,900.00%NITENightstar Therapeutics-0.33%+0.48%+3.65%+16.76%+27.49%WMWELEMENTS Linked to the Morningstar Wide Moat Focus Total Return Index0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAZTDAztlan Global Stock Selection DM SMID ETFN/AN/AN/AN/AN/AN/AN/AN/ALSTLeuthold Select Industries ETFN/AN/AN/AN/AN/AN/AN/AN/ANITENightstar TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AWMWELEMENTS Linked to the Morningstar Wide Moat Focus Total Return IndexN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAZTDAztlan Global Stock Selection DM SMID ETF 2.63Moderate Buy$27.21N/ALSTLeuthold Select Industries ETF 2.76Moderate Buy$36.12N/ANITENightstar Therapeutics 0.00N/AN/AN/AWMWELEMENTS Linked to the Morningstar Wide Moat Focus Total Return Index 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAZTDAztlan Global Stock Selection DM SMID ETFN/AN/AN/AN/AN/AN/ALSTLeuthold Select Industries ETFN/AN/AN/AN/AN/AN/ANITENightstar TherapeuticsN/AN/AN/AN/A$5.89 per shareN/AWMWELEMENTS Linked to the Morningstar Wide Moat Focus Total Return IndexN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAZTDAztlan Global Stock Selection DM SMID ETFN/AN/A12.62∞N/AN/AN/AN/AN/ALSTLeuthold Select Industries ETFN/AN/A17.27∞N/AN/AN/AN/AN/ANITENightstar Therapeutics-$36.86M-$1.26N/AN/AN/AN/A-30.89%-27.65%N/AWMWELEMENTS Linked to the Morningstar Wide Moat Focus Total Return IndexN/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAZTDAztlan Global Stock Selection DM SMID ETF$0.421.54%N/AN/AN/ALSTLeuthold Select Industries ETFN/AN/AN/AN/AN/ANITENightstar TherapeuticsN/AN/AN/AN/AN/AWMWELEMENTS Linked to the Morningstar Wide Moat Focus Total Return IndexN/A0.00%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAZTDAztlan Global Stock Selection DM SMID ETFN/AN/AN/ALSTLeuthold Select Industries ETFN/AN/AN/ANITENightstar TherapeuticsN/A8.548.54WMWELEMENTS Linked to the Morningstar Wide Moat Focus Total Return IndexN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAZTDAztlan Global Stock Selection DM SMID ETFN/ALSTLeuthold Select Industries ETFN/ANITENightstar Therapeutics32.83%WMWELEMENTS Linked to the Morningstar Wide Moat Focus Total Return IndexN/AInsider OwnershipCompanyInsider OwnershipAZTDAztlan Global Stock Selection DM SMID ETFN/ALSTLeuthold Select Industries ETFN/ANITENightstar TherapeuticsN/AWMWELEMENTS Linked to the Morningstar Wide Moat Focus Total Return IndexN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAZTDAztlan Global Stock Selection DM SMID ETFN/A1.13 millionN/ANot OptionableLSTLeuthold Select Industries ETFN/A757,000N/AN/ANITENightstar Therapeutics4733.54 millionN/ANot OptionableWMWELEMENTS Linked to the Morningstar Wide Moat Focus Total Return IndexN/A544,000N/ANot OptionableAZTD, LST, WMW, and NITE HeadlinesRecent News About These CompaniesMorningstar Wide Moat Focus (MWMF)December 20, 2023 | investing.comSP500-3030TR S&P 500 Household & Personal Products Index Industry Group - Total ReturnOctober 28, 2023 | seekingalpha.comMorningstar Wide Moat Focus Index Performance Analysis for AdvisorsAugust 18, 2023 | morningstar.comMMorningstar Wide Moat Focus 20 (^MWMFT)May 20, 2023 | finance.yahoo.comKSM 4D Morningstar Wide Moat Focus (KSMF118)March 22, 2023 | uk.investing.comSMID Moat Index Starts StrongJanuary 12, 2023 | seekingalpha.comELEMENTS Linked to the Morningstar Wide Moat Focus Total Return Index (WMW)November 28, 2022 | finance.yahoo.comMOAT: Still Not Appealing After Q3 ReconstitutionSeptember 21, 2022 | seekingalpha.comTop HeadlinesView All Headlines3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military Spend3 Short Squeeze Candidates With Big Catalysts on the HorizonBy Dan Schmidt | July 25, 2025View 3 Short Squeeze Candidates With Big Catalysts on the HorizonHow a Government Loan Changes the Game for Plug PowerBy Jeffrey Neal Johnson | July 4, 2025View How a Government Loan Changes the Game for Plug PowerRocket Lab: Latest Catalysts Bolster the Bull CaseBy Ryan Hasson | July 3, 2025View Rocket Lab: Latest Catalysts Bolster the Bull CasePalo Alto Networks: The All‑in‑One Cybersecurity PowerhouseBy Jeffrey Neal Johnson | July 30, 2025View Palo Alto Networks: The All‑in‑One Cybersecurity PowerhouseAZTD, LST, WMW, and NITE Company DescriptionsAztlan Global Stock Selection DM SMID ETF NYSEARCA:AZTD$27.21 -0.17 (-0.62%) Closing price 08/1/2025 04:10 PM EasternExtended Trading$27.18 -0.03 (-0.11%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Aztlan Global Stock Selection Dm SMID ETF (AZTD) is an exchange-traded fund that mostly invests in extended market equity. The fund tracks an equal-weighted index of 27 mid- and small-cap stocks from developed markets, selected based on six factors: value, cashflow, capital structure, growth, EPS revisions, and price momentum. AZTD was launched on Aug 18, 2022 and is managed by Aztlan.Leuthold Select Industries ETF NYSEARCA:LST$36.12 -0.49 (-1.34%) As of 08/1/2025 04:10 PM EasternThe Leuthold Select Industries ETF (LST) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking capital appreciation by broadly investing in US equity securities. The selection process utilizes a quantitative approach that focuses on shifts in industry groups LST was launched on Jan 21, 2025 and is issued by Leuthold.Nightstar Therapeutics NASDAQ:NITENightstar Therapeutics plc, a clinical-stage gene therapy company, focuses on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases in the United Kingdom. The company's lead product candidate is NSR-REP1, a candidate that is in phase 3 clinical development for the treatment of patients with choroideremia. It is also developing NSR-RPGR, a candidate that is in Phase 1/2 clinical trials for the treatment of patients with X-linked retinitis pigmentosa, an inherited X-linked recessive retinal disease; and NSR-BEST1, a candidate that is in preclinical development stage for the treatment of best vitelliform macular dystrophy. In addition, the company is developing NSR-ABCA4, a candidate that is in preclinical development stage for the treatment of Stargardt disease. The company was founded in 2013 and is headquartered in London, the United Kingdom.ELEMENTS Linked to the Morningstar Wide Moat Focus Total Return Index NYSEARCA:WMW More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Why Bloom Energy Stock Could Break to New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
